Impact of Medication Therapy Management (MTM) Service Model on Multi-morbidity (MMD) Patients with Hypertension: a Pilot RCT

Overview

Journal BMC Geriatr

Publisher Biomed Central

Specialty Geriatrics

Date 2023 Jan 7

PMID 36609228

Authors

Na Li

Jin-Fang Song

Ming-Zhu Zhang

Xiao-Min Lv

Hui-Lian Hua

Yi-Ling Chang

Affiliations

Soon will be listed here.

Abstract

Background: This study explored the impact of MTM service on MMD patients with hypertension.

Methods: A total of 120 MMD inpatients from September to November 2019 were received and randomly divided into intervention group and control group. General services for noninfectious chronic diseases were given to the control group, while a standard MTM service was given to the intervention group. Patients' blood pressure, EQ-5D utility value, readmission rate, drug-related problems, and average daily medication therapy cost were compared between the two groups and within the groups. This was done at the initial admission phase and in the first, third, sixth, and twelfth months after discharge.

Results: The intervention group had significantly lower blood pressure and average daily medication therapy cost 12 months after discharge compared to the control group (systolic blood pressure: P = 0.023, diastolic blood pressure: P < 0.001, average daily medication therapy cost: P = 0.049); the number of DRPs decreased in both groups 12 months after discharge; the number of DRPs solved in the intervention group in the third, sixth and twelfth months after discharge were statistically higher compared with that in the control group (P = 0.013, P = 0.012, P = 0.001); there was no significant difference in the EQ-5D utility value and readmission rate between the two groups (P > 0.05).

Conclusions: MTM implementation in MMD patients can improve health outcomes and reduce healthcare-related costs among MMD patients.

Trial Registration: Chinese Clinical Trial Register ChiCTR2200065111, date of registration: October 28, 2022.

Citing Articles

Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysis.

Akasaki Y, Suematsu Y, Azushima K, Shiga Y, Sakima A, Satoh M Hypertens Res. 2025; .

PMID: 39962166 DOI: 10.1038/s41440-025-02152-9.

Remote follow-up by pharmacists for blood pressure control in patients with hypertension: a systematic review and a meta-analysis of randomized controlled trials.

Matsumoto N, Nakai T, Sakakibara M, Aimiya Y, Sugiura S, Lee J Sci Rep. 2024; 14(1):2535.

PMID: 38291114 PMC: 10827741. DOI: 10.1038/s41598-024-52894-8.

Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.

Amin K, Bethel G, Jackson 2nd L, Essien U, Sloan C Curr Atheroscler Rep. 2023; 25(12):1113-1127.

PMID: 38108997 PMC: 11044811. DOI: 10.1007/s11883-023-01180-5.

The Surgical Timing and Prognoses of Elderly Patients with Hip Fractures: A Retrospective Analysis.

Sun L, Wang C, Zhang M, Li X, Zhao B Clin Interv Aging. 2023; 18:891-899.

PMID: 37287528 PMC: 10243344. DOI: 10.2147/CIA.S408903.

References

Zhao X, Xu R, Wang Y, Zhu W, Hu H, Shen Z . Impacts of Pharmacists-Managed Oncology Outpatient Clinic on Resolving Drug-Related Problems in Ambulatory Neoplasm Patients: A Prospective Study in China. Inquiry. 2021; 58:469580211009662. PMC: 8047945. DOI: 10.1177/00469580211009662. View

Oliveira D, Brummel A, Miller D . Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System. J Manag Care Spec Pharm. 2020; 26(9):1057-1066. PMC: 10391185. DOI: 10.18553/jmcp.2020.26.9.1057. View

Silva Almodovar A, Nahata M . Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries. J Manag Care Spec Pharm. 2019; 25(5):573-577. PMC: 10398061. DOI: 10.18553/jmcp.2019.25.5.573. View

Reeder C . Overview of pharmacoeconomics and pharmaceutical outcomes evaluations. Am J Health Syst Pharm. 1995; 52(19 Suppl 4):S5-8. DOI: 10.1093/ajhp/52.19_Suppl_4.S5. View

Qu C, Meng L, Wang N, Chen Y, Yang X, Wang J . Identify and categorize drug-related problems in hospitalized surgical patients in China. Int J Clin Pharm. 2019; 41(1):13-17. DOI: 10.1007/s11096-018-0777-7. View

Rencz F, Brodszky V, Gulacsi L, Golicki D, Ruzsa G, Pickard A . Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary. Value Health. 2020; 23(9):1235-1245. DOI: 10.1016/j.jval.2020.03.019. View

Ulley J, Harrop D, Ali A, Alton S, Fowler Davis S . Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review. BMC Geriatr. 2019; 19(1):15. PMC: 6339421. DOI: 10.1186/s12877-019-1031-4. View

Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A . A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ. 2003; 169(1):17-22. PMC: 164937. View

Hepler C, Strand L . Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47(3):533-43. View

10.

Morisky D, Ang A, Krousel-Wood M, Ward H . Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5):348-54. PMC: 2562622. DOI: 10.1111/j.1751-7176.2008.07572.x. View

11.

. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2016; 389(10064):37-55. PMC: 5220163. DOI: 10.1016/S0140-6736(16)31919-5. View

12.

Alosaimy S, Vaidya A, Day K, Stern G . Effect of a Pharmacist-Driven Medication Management Intervention Among Older Adults in an Inpatient Setting. Drugs Aging. 2019; 36(4):371-378. DOI: 10.1007/s40266-018-00634-9. View

13.

Hale G, Moreau C, Joseph T, Phyu J, Merly N, Tadros N . Improving Medication Adherence in an ACO Primary Care Office With a Pharmacist-Led Clinic: A Report From the ACORN SEED. J Pharm Pract. 2020; 34(6):888-893. DOI: 10.1177/0897190020934271. View

14.

Peterson C, Gustafsson M . Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern Sweden. Drugs Real World Outcomes. 2017; 4(2):97-107. PMC: 5457311. DOI: 10.1007/s40801-017-0108-7. View

15.

Granas A, Berg C, Hjellvik V, Haukereid C, Kronstad A, Blix H . Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci. 2010; 32(3):394-403. DOI: 10.1007/s11096-010-9385-x. View

16.

Bos J, Kalkman G, Groenewoud H, Van den Bemt P, De Smet P, Nagtegaal J . Prediction of clinically relevant adverse drug events in surgical patients. PLoS One. 2018; 13(8):e0201645. PMC: 6107128. DOI: 10.1371/journal.pone.0201645. View

17.

Quinn K, Shurrab M, Gitau K, Kavalieratos D, Isenberg S, Stall N . Association of Receipt of Palliative Care Interventions With Health Care Use, Quality of Life, and Symptom Burden Among Adults With Chronic Noncancer Illness: A Systematic Review and Meta-analysis. JAMA. 2020; 324(14):1439-1450. PMC: 8094426. DOI: 10.1001/jama.2020.14205. View

18.

Wang L, Chen Z, Zhang M, Zhao Z, Huang Z, Zhang X . [Study of the prevalence and disease burden of chronic disease in the elderly in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2019; 40(3):277-283. DOI: 10.3760/cma.j.issn.0254-6450.2019.03.005. View

19.

Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019; 5(12):1749-1768. PMC: 6777271. DOI: 10.1001/jamaoncol.2019.2996. View

20.

Wang X, Wang S, Yu X, Ma Z, Wang H, Yang J . Impact of pharmacist-led medication therapy management in ambulatory elderly patients with chronic diseases. Br J Clin Pharmacol. 2021; 87(7):2937-2944. DOI: 10.1111/bcp.14709. View